Cumberland Pharmaceuticals Inc. announced that the FDA has approved expanded labeling for Caldolor an intravenously delivered formulation of ibuprofen, to now include use in infants
Cumberland Pharmaceuticals announced the results of a Level 1 Trauma Center study recently published in the Journal of Orthopedic Trauma.